Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ramos

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Medical Economics|August 27, 2020
Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricingNimer S Alkhatib, Kenneth Ramos, Brian Erstad, et al.
Journal of Medical Economics|August 27, 2020
Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricingNimer S Alkhatib, Kenneth Ramos, Brian Erstad, et al.
Journal of Medical Economics|August 27, 2020
Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricingNimer S Alkhatib, Ali McBride, Sandipan Bhattacharjee, et al.
Sub-Cellular Biochemistry|October 27, 2022
Role of the Histone Acetyl Transferase MOF and the Histone Deacetylase Sirtuins in Regulation of H4K16ac During DNA Damage Repair and Metabolic Programming: Implications in Cancer and AgingTej K Pandita, Clayton R Hunt, Vipin Singh, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 26, 2020
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart FailureNimer Alkhatib, Nancy K Sweitzer, Christopher S Lee, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Toxicity assessment of complex mixtures remains a goalKirby C Donnelly, Rebecca Lingenfelter, Leslie Cizmas, et al.
Oncogene|May 8, 2024
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistanceChandrima Das, Apoorva Bhattacharya, Swagata Adhikari, et al.
Cancer Research Communications|March 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell ProfilesYitian Xu, Licheng Zhang, Jose Thaiparambil, et al.
BMC Proceedings|November 18, 2017
Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities - a National Heart, Lung, and Blood Institute workshop reportM Larissa Avilés-Santa, John Heintzman, Nangel M Lindberg, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Medical Economics|August 27, 2020
Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricingNimer S Alkhatib, Kenneth Ramos, Brian Erstad, et al.
Journal of Medical Economics|August 27, 2020
Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricingNimer S Alkhatib, Kenneth Ramos, Brian Erstad, et al.
Journal of Medical Economics|August 27, 2020
Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricingNimer S Alkhatib, Ali McBride, Sandipan Bhattacharjee, et al.
Sub-Cellular Biochemistry|October 27, 2022
Role of the Histone Acetyl Transferase MOF and the Histone Deacetylase Sirtuins in Regulation of H4K16ac During DNA Damage Repair and Metabolic Programming: Implications in Cancer and AgingTej K Pandita, Clayton R Hunt, Vipin Singh, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 26, 2020
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart FailureNimer Alkhatib, Nancy K Sweitzer, Christopher S Lee, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Toxicity assessment of complex mixtures remains a goalKirby C Donnelly, Rebecca Lingenfelter, Leslie Cizmas, et al.
Oncogene|May 8, 2024
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistanceChandrima Das, Apoorva Bhattacharya, Swagata Adhikari, et al.
Cancer Research Communications|March 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell ProfilesYitian Xu, Licheng Zhang, Jose Thaiparambil, et al.
BMC Proceedings|November 18, 2017
Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities - a National Heart, Lung, and Blood Institute workshop reportM Larissa Avilés-Santa, John Heintzman, Nangel M Lindberg, et al.
Pageof 2